BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23819951)

  • 1. Novel targeted therapies in peripheral T cell lymphoma.
    Jagadeesh D; Smith MR
    Discov Med; 2013 Jun; 15(85):367-78. PubMed ID: 23819951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
    Coiffier B; Federico M; Caballero D; Dearden C; Morschhauser F; Jäger U; Trümper L; Zucca E; Gomes da Silva M; Pettengell R; Weidmann E; d'Amore F; Tilly H; Zinzani PL
    Cancer Treat Rev; 2014 Oct; 40(9):1080-8. PubMed ID: 25199959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for peripheral T-cell lymphomas.
    Foss FM
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):43-56. PubMed ID: 23768640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTCL therapies: a review of treatment and outline of novel therapies.
    Khan N; Cheson BD
    Am J Ther; 2013; 20(5):524-33. PubMed ID: 23528371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.
    Rodríguez J; Gutiérrez A; Martínez-Delgado B; Perez-Manga G
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):181-98. PubMed ID: 19056295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
    Majhail NS; Burns LJ
    Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
    Rodriguez-Abreu D; Filho VB; Zucca E
    Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)].
    Kinoshita T
    Nihon Rinsho; 2014 Mar; 72(3):512-8. PubMed ID: 24724412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options in peripheral T cell lymphoma.
    Zhang Y; Xu W; Liu H; Li J
    J Hematol Oncol; 2016 Apr; 9():37. PubMed ID: 27071634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes.
    Allen PB; Pro B
    Curr Oncol Rep; 2020 Apr; 22(5):44. PubMed ID: 32297075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted molecular therapy in peripheral T-cell lymphomas.
    Roncolato F; Gazzola A; Zinzani PL; Pileri SA; Piccaluga PP
    Expert Rev Hematol; 2011 Oct; 4(5):551-62. PubMed ID: 21939422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drug therapies in peripheral T-cell lymphoma.
    Howman RA; Prince HM
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):457-72. PubMed ID: 21417858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.
    Chen AI; Advani RH
    J Natl Compr Canc Netw; 2008 Apr; 6(4):428-35. PubMed ID: 18433608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
    O'Connor OA; Bhagat G; Ganapathi K; Pedersen MB; D'Amore F; Radeski D; Bates SE
    Clin Cancer Res; 2014 Oct; 20(20):5240-54. PubMed ID: 25320373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral T-cell lymphoma: diagnosis and treatment].
    Reimer P; Hentrich M
    Dtsch Med Wochenschr; 2006 Mar; 131(13):685-90. PubMed ID: 16555177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
    Ma H; O'Connor OA; Marchi E
    Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of advanced-stage peripheral T-cell lymphomas.
    Kimby E
    Curr Hematol Malig Rep; 2007 Oct; 2(4):242-8. PubMed ID: 20425376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T-cell lymphoma in children and adolescents: a single-institution experience.
    Al Mahmoud R; Weitzman S; Schechter T; Ngan B; Abdelhaleem M; Alexander S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):611-6. PubMed ID: 23042011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.